CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

General Electric HealthCare spinoff date and details in full as GE confirms plans

By Jenal Mehta

13:25, 13 October 2022

GE factory
GE confirms details of its healthcare spin off. Photo - Getty Images

General Electric’s (GE) healthcare spin off is due to take place in January. The American conglomerate has now confirmed the details of this event.

In November 2021, the group announced its plan to split the company into three separate publicly-traded companies, each focused on energy, healthcare and aviation.

The announcement didn't help to lift the stock, however. The GE share price is currently trading 35% lower than it was a year ago after it battled worker and equipment shortages.

What is your sentiment on GE?

Vote to see Traders sentiment!

General Electric (GE) Price Chart


The spinoff will be named GE HealthCare and will retain the current healthcare unit with a new set of board members.

The 10 member board team will include Peter Arduini as chief executive (CEO) of GE Healthcare, along with the GE CEO Larry Culp. There will also be executives from Honeywell (HON) and Amazon (AMZN) Web Services.

“With this initial group of directors, we have a highly qualified and capable board that will enable GE HealthCare to hit the ground running,” said Culp.

On 11 October, GE filed form 10 with the Securities and Exchange Commission (SEC) in which it outlined four business segments – imaging, ultrasound, patient care solutions and pharmaceutical diagnostics.

The company confirmed that GE HealthCare will issue debt securities, in order to pay outstanding obligations over time.


0.48 Price
+6.120% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168


2,411.42 Price
-0.180% 1D Chg, %
Long position overnight fee -0.0191%
Short position overnight fee 0.0109%
Overnight fee time 21:00 (UTC)
Spread 0.60


3,133.70 Price
+0.460% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00


57,867.95 Price
+0.420% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

More details are to come on investor day to be held by GE HealthCare on 8 December.


What does it mean for investors?

GE’s stock has lowered significantly since the start of 2022. It faced turbulence after pandemic-induced supply chain constraints. Medical equipment deployments, which mostly came from China, heavily impacted the firm. Competitors such as Siemens Healthineers and Philips faced similar issues.

It is completely unknown what price investors should place on the healthcare spin off. However, based on the valuation of Siemens Healthineers, the market value can be placed at around $15bn. GE will retain 19.9% of the new healthcare spin off.

Growth in demand for medical equipment remains robust. Revenue from the current healthcare unit has increased for two consecutive quarters.

By contrast, its renewable energy and energy power businesses have seen a decline in revenue. The healthcare sector arm is likely to remain a steady stream of revenue for the firm.

Markets in this article

AMZN Inc (Extended Hours)
194.35 USD
-0.92 -0.470%
General Electric Co (Extended Hours)
159.03 USD
-2.85 -1.760%
215.22 USD
0.2 +0.090%

Rate this article

Related reading

Capital Com is an execution-only service provider. The material provided in this article is for information purposes only and should not be understood as investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents and has not been prepared in accordance with the legal requirements designed to promote investment research independence. While the information in this communication, or on which this communication is based, has been obtained from sources that believes to be reliable and accurate, it has not undergone independent verification. No representation or warranty, whether expressed or implied, is made as to the accuracy or completeness of any information obtained from third parties. If you rely on the information on this page, then you do so entirely at your own risk.

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading